ERBB2 and breast carcinoma: Gene expression profiling has revealed that PyMT mouse breast tumors model the luminal B molecular subtype of human breast cancer, with overexpression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (Her2/neu) [7,10,13].